Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Resistance news

Show

From To
Viral load blips are likely due to lab error and not cause for concern

Viral load blips are the result of statistical fluctuations in the test used to measure viral load levels, and not clinically significant, according to the

Published
16 February 2005
By
Edwin J. Bernard
Commentary: How important is the New York resistance case?

New York City’s health department has announced that a gay man in his 40s has been newly infected with a strain of HIV resistant to

Published
14 February 2005
By
Michael Carter
CD4-guided structured treatment interruptions safe in patients at high risk of resistance

Patients at high risk of developing drug resistance can undergo CD4-guided structured treatment interruptions without developing major HIV drug resistance mutations, according to a small

Published
09 February 2005
By
Christopher Gadd
Risk of resistance with nevirapine-containing HAART after pregnancy, even when stopped correctly

Women with a wide variety of HIV-1 subtypes, including B, B/G, F2 and G, who take nevirapine-containing HAART during the third trimester of their pregnancy

Published
02 February 2005
By
Edwin J. Bernard
Substantial, but imperfect adherence a major risk factor for resistance amongst patients starting HAART

Individuals starting HAART for the first time with a high viral load, low CD4 cell count, and substantial, but imperfect levels of adherence are significantly

Published
27 January 2005
By
Michael Carter
Resistance mutations persist for many years in untreated HIV-positive people

Many untreated HIV-positive patients maintain resistance mutations for many years after infection, according to a large study from the United States published in the 1st

Published
25 January 2005
By
Christopher Gadd
Low, detectable viral load on HAART associated with high levels of activated CD4 and CD8 T-cells

Two recent studies have helped to explain how patients taking highly active antiretroviral therapy (HAART) but who have low, detectable viral loads can maintain stable

Published
20 January 2005
By
Christopher Gadd
Low rate of treatment failure with tenofovir, 3TC and AZT

German investigators have found a low rate of treatment failure amongst patients receiving the nucleoside analogues (NRTIs) AZT and 3TC in combination with the nucleotide

Published
12 January 2005
By
Michael Carter
Treatment failure, not transmission, will be main source of drug resistant HIV in Africa in next 10 years

At currently planned levels of treatment coverage in Africa, transmission of drug resistant virus will remain far below the levels seen in the developed world

Published
11 January 2005
By
Keith Alcorn
Drug-resistant virus acquired during HIV infection remains stable and persistent

A three-year study from an HIV treatment centre in Brighton, East Sussex, has found that drug-resistant strains of HIV remain stable and can persist for

Published
13 December 2004
By
Edwin J. Bernard

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.